Literature DB >> 10329594

Impairment of TNF-receptor-1 signaling but not fas signaling diminishes T-cell apoptosis in myelin oligodendrocyte glycoprotein peptide-induced chronic demyelinating autoimmune encephalomyelitis in mice.

R Bachmann1, H P Eugster, K Frei, A Fontana, H Lassmann.   

Abstract

T-cell apoptosis in inflammatory demyelinating lesions of chronic myelin oligodendrocyte glycoprotein peptide35-55 induced autoimmune encephalomyelitis was studied in several different gene knockout mice as well as their wild-type counterparts. The gene deletions included tumor necrosis factor (TNF) alpha, lymphotoxin, TNF receptor 1 or 2, Fas-L, inducible nitric oxide synthase, perforin, and interleukin1beta-converting enzyme. Impairment of the TNF receptor 1 pathway led to a 50% reduction of T-cell apoptosis in the central nervous system lesions, whereas the other genetic deletions showed no significant effect. Our study thus identified the TNF receptor 1 signaling pathway as one mechanism responsible for the removal of T lymphocytes from inflammatory demyelinating lesions of the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329594      PMCID: PMC1866600          DOI: 10.1016/S0002-9440(10)65395-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  28 in total

1.  Fas ligand-induced apoptosis as a mechanism of immune privilege.

Authors:  T S Griffith; T Brunner; S M Fletcher; D R Green; T A Ferguson
Journal:  Science       Date:  1995-11-17       Impact factor: 47.728

2.  A novel domain within the 55 kd TNF receptor signals cell death.

Authors:  L A Tartaglia; T M Ayres; G H Wong; D V Goeddel
Journal:  Cell       Date:  1993-09-10       Impact factor: 41.582

3.  Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-alpha double-deficient mice.

Authors:  H P Eugster; M Muller; U Karrer; B D Car; B Schnyder; V M Eng; G Woerly; M Le Hir; F di Padova; M Aguet; R Zinkernagel; H Bluethmann; B Ryffel
Journal:  Int Immunol       Date:  1996-01       Impact factor: 4.823

4.  Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections.

Authors:  I Garcia; Y Miyazaki; K Araki; M Araki; R Lucas; G E Grau; G Milon; Y Belkaid; C Montixi; W Lesslauer
Journal:  Eur J Immunol       Date:  1995-08       Impact factor: 5.532

Review 5.  The Fas death factor.

Authors:  S Nagata; P Golstein
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

6.  Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme.

Authors:  K Kuida; J A Lippke; G Ku; M W Harding; D J Livingston; M S Su; R A Flavell
Journal:  Science       Date:  1995-03-31       Impact factor: 47.728

7.  Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase.

Authors:  J D MacMicking; C Nathan; G Hom; N Chartrain; D S Fletcher; M Trumbauer; K Stevens; Q W Xie; K Sokol; N Hutchinson
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

8.  Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques.

Authors:  R Gold; M Schmied; G Giegerich; H Breitschopf; H P Hartung; K V Toyka; H Lassmann
Journal:  Lab Invest       Date:  1994-08       Impact factor: 5.662

9.  A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells.

Authors:  I Mendel; N Kerlero de Rosbo; A Ben-Nun
Journal:  Eur J Immunol       Date:  1995-07       Impact factor: 5.532

10.  Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease.

Authors:  M Y Braun; B Lowin; L French; H Acha-Orbea; J Tschopp
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

View more
  11 in total

1.  Role of tumor necrosis factor receptors in regulating CD8 T-cell responses during acute lymphocytic choriomeningitis virus infection.

Authors:  M Suresh; Anju Singh; Christopher Fischer
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Absence of reuptake of serotonin influences susceptibility to clinical autoimmune disease and neuroantigen-specific interferon-gamma production in mouse EAE.

Authors:  H H Hofstetter; R Mössner; K P Lesch; R A Linker; K V Toyka; R Gold
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

3.  Elevated interferon gamma expression in the central nervous system of tumour necrosis factor receptor 1-deficient mice with experimental autoimmune encephalomyelitis.

Authors:  Rachel D Wheeler; Simone P Zehntner; Lisa M Kelly; Lyne Bourbonnière; Trevor Owens
Journal:  Immunology       Date:  2006-06-16       Impact factor: 7.397

4.  Galectin-9 protein is up-regulated in astrocytes by tumor necrosis factor and promotes encephalitogenic T-cell apoptosis.

Authors:  Andrew J Steelman; Roger Smith; C Jane Welsh; Jianrong Li
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

Review 5.  Monoclonal antibody therapy-associated neurological disorders.

Authors:  Xavier Bosch; Albert Saiz; Manuel Ramos-Casals
Journal:  Nat Rev Neurol       Date:  2011-01-25       Impact factor: 42.937

6.  MADD, a splice variant of IG20, is indispensable for MAPK activation and protection against apoptosis upon tumor necrosis factor-alpha treatment.

Authors:  Bapi Raju V V S N Kurada; Liang Cheng Li; Nirupama Mulherkar; Mahesh Subramanian; Kanteti V Prasad; Bellur S Prabhakar
Journal:  J Biol Chem       Date:  2009-03-16       Impact factor: 5.157

7.  Anti-inflammatory effects of tumour necrosis factor (TNF)-alpha are mediated via TNF-R2 (p75) in tolerogenic transforming growth factor-beta-treated antigen-presenting cells.

Authors:  Sharmila Masli; Bruce Turpie
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

Review 8.  Cytokine shifts and tolerance in experimental autoimmune encephalomyelitis.

Authors:  Tanuja Chitnis; Samia J Khoury
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

9.  Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model.

Authors:  Kuriko Kagitani-Shimono; Ikuko Mohri; Yasushi Fujitani; Kinuko Suzuki; Keiichi Ozono; Yoshihiro Urade; Masako Taniike
Journal:  J Neuroinflammation       Date:  2005-04-06       Impact factor: 8.322

Review 10.  A New Venue of TNF Targeting.

Authors:  Sophie Steeland; Claude Libert; Roosmarijn E Vandenbroucke
Journal:  Int J Mol Sci       Date:  2018-05-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.